Detailed answers about ADVANCED UROLOGY CLINICAL SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was ADVANCED UROLOGY CLINICAL SOLUTIONS LTD founded?
ADVANCED UROLOGY CLINICAL SOLUTIONS LTD was officially incorporated on 21 January 2026 and is registered under company number 16977227. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADVANCED UROLOGY CLINICAL SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADVANCED UROLOGY CLINICAL SOLUTIONS LTD?
ADVANCED UROLOGY CLINICAL SOLUTIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADVANCED UROLOGY CLINICAL SOLUTIONS LTD do?
ADVANCED UROLOGY CLINICAL SOLUTIONS LTD operates in the following sectors: 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ADVANCED UROLOGY CLINICAL SOLUTIONS LTD's registered address?
The registered office address of ADVANCED UROLOGY CLINICAL SOLUTIONS LTD is ADVANCED UROLOGY CLINICAL SOLUTIONS LTD - SUITE A, 82 JAMES CARTER ROAD, MILDENHALL, UNITED KINGDOM, IP28 7DE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADVANCED UROLOGY CLINICAL SOLUTIONS LTD financially stable?
Financial accounts for ADVANCED UROLOGY CLINICAL SOLUTIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.